Skip to Content
Merck
  • [Jumper's knee. Surgery and arthroscopic treatment with scraping and povidone collagen in high-performance athletes].

[Jumper's knee. Surgery and arthroscopic treatment with scraping and povidone collagen in high-performance athletes].

Acta ortopedica mexicana (2007-12-28)
Eduardo Caldelas Cuéllar, Nicolás Zarur Mina
ABSTRACT

The jumper's knee or patellar tendonitis is a common injury in the athlete with an incidence between 14% and 16% among high-performance athletes. In addition to an overuse injury, there are some intrinsic factors for its development. Conservative treatment is indicated for the initial form, but when it fails, surgical treatment should be performed with an appropriate rehabilitation program. We retrospectively studied 18 high performance athletes in various disciplines, with an average age of 22 years, operated by arthroscopy and mini-arthrotomy scraping and application of povidone collagen sponge between March 2001 and December 2005. There after patients underwent a rehabilitation program specific for their return to their athletic activity. The patients returned to their sports activity in an average of 15 weeks, with functional knees without pain, with full range of motion. We did not find postoperative fibrosis. The results were similar and slightly better in time of return to sports activities to those reported in the world literature, with the difference in follow up. According to the clinical evaluation, treatment performed allows functional improvement with a return to athletic activity in a reasonable time.

MATERIALS
Product Number
Brand
Product Description

Povidone, European Pharmacopoeia (EP) Reference Standard
Supelco
Poly(vinylpolypyrrolidone), ~110 μm particle size
Sigma-Aldrich
Kollidon® 25
Supelco
Povidone, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Crospovidone, United States Pharmacopeia (USP) Reference Standard
USP
Povidone, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Povidone, meets USP testing specifications
Crospovidone, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Polyvinylpyrrolidone, for molecular biology, nucleic acid hybridization tested, mol wt 360,000
Sigma-Aldrich
Polyvinylpyrrolidone, K 90
Sigma-Aldrich
Polyvinylpyrrolidone, K 30
Sigma-Aldrich
Polyvinylpyrrolidone solution, K 60, 45% in H2O
Sigma-Aldrich
Polyvinylpyrrolidone, average mol wt 10,000
Sigma-Aldrich
Polyvinylpyrrolidone, powder, average Mw ~29,000
Sigma-Aldrich
Polyvinylpyrrolidone, powder, average Mw ~55,000
Sigma-Aldrich
Polyvinylpyrrolidone, average Mw ~1,300,000 by LS
Sigma-Aldrich
Polyvinylpyrrolidone, suitable for plant cell culture, average mol wt 10,000
Sigma-Aldrich
Polyvinylpyrrolidone, mol wt (number average molecular weight Mn 360kDa)
Sigma-Aldrich
Polyvinylpyrrolidone, powder, BioXtra, suitable for mouse embryo cell culture
Sigma-Aldrich
Polyvinylpyrrolidone, average mol wt 40,000
Sigma-Aldrich
Polyvinylpyrrolidone, K 25, tested according to Ph. Eur.